Bio-Techne Corp (TECH)
Fixed asset turnover
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 1,219,634 | 1,208,768 | 1,196,015 | 1,171,582 | 1,159,059 | 1,154,281 | 1,144,999 | 1,143,982 | 1,136,702 | 1,123,611 | 1,119,841 | 1,117,536 | 1,105,600 | 1,076,399 | 1,029,575 | 984,552 | 931,032 | 847,838 | 798,966 | 759,647 |
| Property, plant and equipment | US$ in thousands | — | — | — | — | — | — | — | — | 226,200 | 223,571 | 223,851 | 293,843 | 288,798 | 218,398 | 276,107 | 278,530 | 281,741 | 198,975 | 195,602 | 191,677 |
| Fixed asset turnover | — | — | — | — | — | — | — | — | 5.03 | 5.03 | 5.00 | 3.80 | 3.83 | 4.93 | 3.73 | 3.53 | 3.30 | 4.26 | 4.08 | 3.96 |
June 30, 2025 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $1,219,634K ÷ $—K
= —
The fixed asset turnover ratio for Bio-Techne Corp demonstrates notable fluctuations over the examined periods. Beginning at 3.96 as of September 30, 2020, the ratio experienced a steady increase, reaching a peak of 4.26 by March 31, 2021, indicating improved efficiency in utilizing fixed assets to generate revenue. However, a decline occurred in the subsequent quarter, falling to 3.30 by June 30, 2021, suggesting a temporary reduction in asset utilization effectiveness. The ratio partially recovered to 3.53 by September 2021 and continued its upward trend, reaching 3.73 by December 31, 2021.
A significant increase was observed in the period ending March 31, 2022, where the ratio jumped to 4.93, signaling substantial improvement in asset utilization or increased sales relative to fixed assets. This higher level was maintained with ratios of 3.83 and 3.80 in the following two quarters, before reaching 5.00 as of December 31, 2022, and further increasing slightly to 5.03 by the end of March 2023 and June 2023.
Overall, the trend indicates an enhanced efficiency in utilizing fixed assets to generate revenue toward the latter part of the observed period, with the ratios stabilizing around the 5.00 mark. Data beyond June 2023 is unavailable for subsequent periods up to September 2025. The observed increases in the fixed asset turnover suggest that Bio-Techne Corp has managed to operate its assets more effectively during this timeframe, likely through optimized asset management or increased sales productivity.
Peer comparison
Jun 30, 2025